Stem Cell Transplant Program
PO Box 800334
Charlottesville, VA 22908-0334
Direct phone: 434-243-6840
Total transplants by cell source
- Marrow: 5
- PBSC: 90
- Cord Blood: 1
- Autologous (PBSC or Marrow): 161
About the center
The UVA Health Cancer Center is an NCI-designated Comprehensive Cancer Center and our Stem Cell Transplant Program is FACT accredited. We perform autologous, related/unrelated allogeneic, haploidentical and cord blood transplants in adult patients. We improve lives through outstanding and compassionate transplant and cell therapy. We support our patients, families and team members through a collaborative, diverse community bound by values of empathy, caring, trust, and respect. We improve the lives of future patients through innovative research.
This center has been performing allogeneic transplants since 2012 and has been an NMDP/Be The Match transplant center since April 2014.
Adult - Karen Ballen, Tamila Kindwall-Keller, Indumathy Varadarajan, Leonid Volodin
Marrow/PBSC, single cord, and double cord
Cord blood transplants performed on
Other programs and services
Nearby affordable suites and hotels offer discounted rates for post-transplant patients. We have a housing assistance program available for low income patients and families, as well as gas and food gift cards avail for emergency use and access to a community food bank. Patients are provided with social work, mental health, and chaplaincy support throughout the process.
Overall center survival
Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center.
The survival information we have for this center includes ONLY:
- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2017, 2018, 2019, and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 121 patients.
The actual 1-year survival of these patients is 74.3%.
Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 67.6% and 82.4%.
For help with understanding these statistics, please see Understanding Transplant Outcomes.
For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report at bloodcell.transplant.hrsa.gov.
Transplants reported (From January 1, 2019 to December 31st, 2020 as reported by the centers)
|Both marrow & PBSC
Transplants by disease
Number of transplants by age reported from January 1, 2019 to December 31st, 2020 (includes marrow, PBSC and cord blood)
Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants for this disease can be found:
Transplant center resources
Transplant center coordinator:
Be The Match patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
Inside the United States: 1 (888) 999-6743
Outside the United States: 1 (763) 406-3410.
(Long distance or international charges may apply.)